Editorial: Novel phenotyping and risk stratification strategies for heart failure

Front Cardiovasc Med. 2023 Jan 5:9:1115991. doi: 10.3389/fcvm.2022.1115991. eCollection 2022.

Jeffrey Shi Kai Chan¹, Ana Ciobanu^{2

3}, Ying Liu⁴, Aggeliki Gkouziouta⁵, Tong Liu⁶

¹ Heart Failure and Structural Heart Disease Research Unit, Cardiovascular Analytics Group, Hong Kong, Hong Kong SAR, China.
² Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
³ Department of Internal Medicine and Cardiology, Theodor Burghele Clinical Hospital, Bucharest, Romania.
⁴ Heart Failure and Structural Cardiology Division, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
⁵ Onassis Cardiac Surgery Center, Athens, Greece.
⁶ Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.

No abstract available

Keywords: epidemiology; heart failure; pathophysiology; phenotype; risk stratification.

Publication types